Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Genelux Corp Is A Late-Stage Biopharmaceutical Firm Focused On Developing Oncolytic Viral Immunotherapies For Cancer. Its Pipeline Includes Clinical And Preclinical Candidates Designed To Target Tumor Cells And Stimulate An Immune Response Against Tumor-Specific Antigens. The Company Is Focused On The Development Of Next-Generation Oncolytic Viral Immunotherapies That Are Designed To Generate A Personalized Multi-Prong Attack To Overwhelm A Tumor'S Sophisticated Defense Mechanisms.